-
Wall Street erases most of the early rally fuelled by better-than-expected results from major US banks. The Russell 2000 index loses 0.93%, the Nasdaq adds 0.1% and the S&P 500 gains 0.15%. The Dow Jones benchmark was the best performer, gaining 0.4% at the time of publication.
-
Banks presented better interest performance thanks to high interest rates.
-
Next week, financial companies will continue to publish their results. In addition, we will hear reports from Tesla, Netflix and IBM, among others.
-
The UoM data are surprising in two respects: an improvement in consumer sentiment, but also a rebound in inflation expectations, which is not a very good sign from the perspective of the Fed decision. On the other hand, the Fed itself expects that inflation could be fairly flat next year.
-
AT&T (ATT.US) shares are sliding to their lowest levels in 20 years after a downgraded recommendation from JP Morgan, which sees growing competition around the company.
-
Ericcson (ERICB.SE) and Nokia (NOKIA.FI) were subject to depressed sentiment today after an earnings warning and the release of weak results from Ericcson.
-
WTI and Brent crude oil are down more than 2% today, breaking a 3-day upward streak. The rises stopped exactly at the limit set by the 200-day exponential moving average (EMA 200).
-
Gold also capped the gains, despite EURUSD holding above 1.12
-
The US Federal Court's decision that XRP tokens do not constitute securities led to a frenzied rally on XRP. It is now up around 70% compared to before the decision. Analysts estimate whether a similar kind fate may await Coinbase (COIN.US) and Binance (BINANCECOIN), which are also under US regulatory pressure.
Daily Summary: Hot inflation and awaiting for news from Beijing
Trump–Xi: Who represents business and how are markets reacting?
US OPEN: Higher inflation to cap gains?
Birkenstock shares hit lowest level since IPO following earnings report 💥
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
